Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Kohanbash

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Scientific Reports|March 4, 2024
ImmunoPET imaging of TIGIT in the glioma microenvironmentSarah R Vincze, Ambika P Jaswal, Stephen C Frederico, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppressionJuliana Hofstätter Azambuja, Saigopalakrishna S Yerneni, Lisa M Maurer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2010
Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant gliomaHideho Okada, Pawel Kalinski, Ryo Ueda, et al.
The Journal of Experimental Medicine|December 6, 2017
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapyZinal S Chheda, Gary Kohanbash, Kaori Okada, et al.
Ebiomedicine|September 16, 2021
Novel theranostic agent for PET imaging and targeted radiopharmaceutical therapy of tumour-infiltrating immune cells in gliomaAlexandra Foster, Shubhanchi Nigam, David S Tatum, et al.
Journal of Translational Medicine|October 15, 2024
Dual-labeled anti-GD2 targeted probe for intraoperative molecular imaging of neuroblastomaLauren Taylor Rosenblum, ReidAnn E Sever, Ryan Gilbert, et al.
Journal of Neurotrauma|June 13, 2025
Sexually Dimorphic Responses Reveal Multifaceted Benefits of Glibenclamide in Traumatic Brain InjuryAnupama Rani, Sudhanshu P Raikwar, Wonsuk Yoo, et al.
Cancer Research|June 16, 2019
Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine GliomasRobert F Koncar, Brittany R Dey, Ann-Catherine J Stanton, et al.
Neuron|July 17, 2024
A single-cell atlas deconstructs heterogeneity across multiple models in murine traumatic brain injury and identifies novel cell-specific targetsRuchira M Jha, Dhivyaa Rajasundaram, Chaim Sneiderman, et al.
The Journal of Clinical Investigation|July 6, 2021
Chitinase-3-like 1 protein complexes modulate macrophage-mediated immune suppression in glioblastomaApeng Chen, Yinan Jiang, Zhengwei Li, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Scientific Reports|March 4, 2024
ImmunoPET imaging of TIGIT in the glioma microenvironmentSarah R Vincze, Ambika P Jaswal, Stephen C Frederico, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppressionJuliana Hofstätter Azambuja, Saigopalakrishna S Yerneni, Lisa M Maurer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2010
Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant gliomaHideho Okada, Pawel Kalinski, Ryo Ueda, et al.
The Journal of Experimental Medicine|December 6, 2017
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapyZinal S Chheda, Gary Kohanbash, Kaori Okada, et al.
Ebiomedicine|September 16, 2021
Novel theranostic agent for PET imaging and targeted radiopharmaceutical therapy of tumour-infiltrating immune cells in gliomaAlexandra Foster, Shubhanchi Nigam, David S Tatum, et al.
Journal of Translational Medicine|October 15, 2024
Dual-labeled anti-GD2 targeted probe for intraoperative molecular imaging of neuroblastomaLauren Taylor Rosenblum, ReidAnn E Sever, Ryan Gilbert, et al.
Journal of Neurotrauma|June 13, 2025
Sexually Dimorphic Responses Reveal Multifaceted Benefits of Glibenclamide in Traumatic Brain InjuryAnupama Rani, Sudhanshu P Raikwar, Wonsuk Yoo, et al.
Cancer Research|June 16, 2019
Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine GliomasRobert F Koncar, Brittany R Dey, Ann-Catherine J Stanton, et al.
Neuron|July 17, 2024
A single-cell atlas deconstructs heterogeneity across multiple models in murine traumatic brain injury and identifies novel cell-specific targetsRuchira M Jha, Dhivyaa Rajasundaram, Chaim Sneiderman, et al.
The Journal of Clinical Investigation|July 6, 2021
Chitinase-3-like 1 protein complexes modulate macrophage-mediated immune suppression in glioblastomaApeng Chen, Yinan Jiang, Zhengwei Li, et al.
Pageof 9